COVID-19 vaccine development pipeline gears up

[gracielle]

Moderna to charge $25-$37 for COVID-19 vaccine, says CEO

Moderna has said its experimental vaccine is 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial

indianexpress.com

 

[gracielle]

Vacuna Covid: cuántas dosis darán, por quiénes arrancarán y cómo armarán operativos las provincias más expuestas

Algunos gobernadores convocan al Ejército para llegar a zonas de alta montaña, como en Salta. En Tucumán ya preparan el padrón y Córdoba superaría los 2,5 millones de destinatarios. - Vacuna Covid Argentina: cuando empieza a aplicarse en el país y quiénes serán los primeros en recibirla

www.clarin.com

24 November 2020
Vaccine against the coronavirus: how many doses will they give, by whom will they start and how the most exposed provinces will set up operations....

Coronavirus: se realizó la primera reunión del Comité de Vacunación | "Será la campaña de vacunación más grande de la historia", aseguró Ginés González García

El presidente Alberto Fernández encabezó la primera reunión del Comité de Vacunación en el Salón Eva Perón de la Casa de Gobierno con la participación del jefe de Gabinete Santiago Cafiero y los ministros de Salud, Ginés González García; de Defensa, Ag...

www.pagina12.com.ar

24 November 2020
"It will be the largest vaccination campaign in history," said Ginés González García
Coronavirus: the first meeting of the Vaccination Committee was held....

Coronavirus: el Gobierno definió quiénes tendrán prioridad para recibir la vacuna y espera arrancar con el operativo en enero

Serán 12.063.000 personas, que incluye a los mayores de 60 años y al personal esencial de distintas áreas. Aún no hay ningún tratamiento aprobado. Alberto Fernández pidió en la primera reunión del Comité de Vacunación realizar “una epopeya”

www.infobae.com

24 November 2020
Coronavirus: the Government defined who will have priority to receive the vaccine and hopes to start the operation in January....

 

[gracielle]

UPDATE: 24 November 2020

Here's what worries some experts about how Chinese companies are developing potential Covid-19 vaccines | CNN

Since the initial outbreak of Covid-19 in Wuhan, China, the country's authorities have largely succeeded in keeping a lid on the virus through tough measures. As Beijing pushes hard to develop a Covid-19 vaccine, CNN's Ivan Watson reports on why some health experts are urging caution.

edition.cnn.com

 

[gracielle]

Coronavirus: identificaron con geolocalización a los 7.735.317 mayores de 60 años que serán vacunados primero

Coronavirus: identificaron con geolocalización a los 7.735.317 mayores de 60 años que serán vacunados primero

www.lanacion.com.ar

25 November 2020
....According to the report prepared by Ministry of the Interior, through the National Registry of Persons (Renaper), in the first stage of the campaign 7,735,317 persons aged 60 years or over will be included, considered vulnerable population....

 

[gracielle]

Russia's Sputnik V developers call on AstraZeneca to try combining vaccines

Developers of the Sputnik V COVID-19 vaccine said on Thursday that AstraZeneca should try combining its experimental shot with the Russian one to boost efficacy.

www.reuters.com

 

[gracielle]

Searching for antibodies Volunteers from Russia’s coronavirus vaccine trials are conducting their own studies of its effectiveness — Meduza

On August 11, Russia announced the registration of the world’s first coronavirus vaccine, dubbed “Sputnik V.” That said, studies of its effectiveness are not yet complete: there are more than 40,000 volunteers taking part in the ongoing Phase III clinical trials, 75 percent of whom received the...

meduza.io

 

[gracielle]

Moderna files for U.S. vaccine authorization, will seek EU nod

Moderna Inc said on Monday it has applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns.

www.reuters.com

 

[gracielle]

COVID-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval

Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout could begin this year.

www.reuters.com

 

[gracielle]

“La manera natural de que algo pase, es viendo ejemplos a seguir

Vanesa Gottifredi, Jefa del Laboratorio de Ciclo Celular y Estabilidad Genómica de la Fundación Instituto Leloir e investigadora de CONICET, se refirió a la importancia de una política de cupo y remarcó el talento argentino

www.infotechnology.com

1 December 2020
....President Alberto Fernández announced the purchase of 25,000,000 doses of the Russian Sputnik V vaccine and 3,000,000 doses of the Pfizer vaccine....In the official announcement, Alberto Fernández announced that "if everything goes well" the vaccination will begin "by the end of December."....

 

[gracielle]

Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK

The UK is the first country to approve the Pfizer vaccine - with 800,000 doses due to arrive soon.

www.bbc.com